Literature DB >> 1352909

Somatostatin cells in the oxyntic mucosa of hypo- or hypergastrinemic rats.

D Chen1, A Uribe, R Håkanson, F Sundler.   

Abstract

The present report describes the long-term effects of antrectomy, antrum exclusion, portacaval shunt, omeprazole treatment, or the combination of omeprazole treatment and portacaval shunt on the number and density of somatostatin cells in the oxyntic mucosa of the rat. Antrectomy, which is associated with hypogastrinemia, raised the number and density of the somatostatin cells, whereas antrum exclusion and omeprazole treatment, which are associated with hypergastrinemia, reduced the number and density of the somatostatin cells. Portacaval shunt, which is associated with hypogastrinemia, increased both the number and the density. Omeprazole treatment of portacaval--shunted rats suppressed or even reversed the somatostatin cell hyperplasia after portacaval shunt alone. From these findings it is unlikely that gastrin stimulates the proliferation of somatostatin cells in the oxyntic mucosa. In fact, there seems to be an inverse relationship between the serum gastrin concentration and the somatostatin cell number.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1352909     DOI: 10.3109/00365529209000108

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  5 in total

1.  Marked increase in gastric acid secretory capacity after omeprazole treatment.

Authors:  H L Waldum; J S Arnestad; E Brenna; I Eide; U Syversen; A K Sandvik
Journal:  Gut       Date:  1996-11       Impact factor: 23.059

Review 2.  Relationship of ECL cells and gastric neoplasia.

Authors:  H L Waldum; E Brenna; A K Sandvik
Journal:  Yale J Biol Med       Date:  1998 May-Aug

3.  Gastric Corpus Mucosal Hyperplasia and Neuroendocrine Cell Hyperplasia, but not Spasmolytic Polypeptide-Expressing Metaplasia, Is Prevented by a Gastrin Receptor Antagonist in H+/K+ATPase Beta Subunit Knockout Mice.

Authors:  Kristin Matre Aasarød; Helge Lyder Waldum; Astrid Kamilla Stunes; Arne Kristian Sandvik; Arnar Flatberg; Patricia Mjønes; Unni Syversen; Ingunn Bakke; Reidar Fossmark
Journal:  Int J Mol Sci       Date:  2020-01-31       Impact factor: 5.923

4.  Gastroparesis is associated with oxytocin deficiency, oesophageal dysmotility with hyperCCKemia, and autonomic neuropathy with hypergastrinemia.

Authors:  Julia Borg; Olle Melander; Linda Johansson; Kerstin Uvnäs-Moberg; Jens F Rehfeld; Bodil Ohlsson
Journal:  BMC Gastroenterol       Date:  2009-02-25       Impact factor: 3.067

Review 5.  The biology and pathobiology of the ECL cells.

Authors:  R Håkanson; Y Tielemans; D Chen; K Andersson; B Ryberg; H Mattsson; F Sundler
Journal:  Yale J Biol Med       Date:  1992 Nov-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.